Key result
Post-AMI LV dilatation with reduced EF linked to ~44% higher MACCE risk vs preserved function.
Why the study?
It remains unclear how left ventricular geometry and systolic function interact to influence prognosis in real-world patients after acute myocardial infarction.
Does left ventricular dilatation combined with reduced ejection fraction increase the risk of MACCE in patients with acute myocardial infarction?
Observational (n=19,664)
Yes
Does left ventricular dilatation combined with reduced ejection fraction increase the risk of MACCE in patients with acute myocardial infarction?
Integrated assessment of LV geometry and function provides complementary risk stratification beyond conventional LVEF-based assessment after acute myocardial infarction.
May refine post-AMI risk stratification via combined LV geometry-function; leaves open prospective validation before practice change.
Background/aims Left ventricular (LV) remodeling after acute myocardial infarction (AMI) is a key determinant of long-term outcomes. However, it remains unclear how LV geometry and systolic function interact to influence prognosis in real-world populations. We investigated the combined prognostic impact of LV dilatation and systolic dysfunction in patients with AMI. Methods We analyzed 19,664 patients with AMI from nationwide Korean multicenter registries. LV geometry-function phenotypes were defined according to LV end-diastolic dimension (LVEDD ≥53 mm for dilatation) and LV ejection fraction (LVEF ≤50% for reduced systolic function), and categorized as non-dilated/preserved (group A), dilated/preserved (group B), non-dilated/reduced (group C), and dilated/reduced (group D). The primary endpoint was 3-year major adverse cardiac and cerebrovascular events (MACCE), defined as cardiac death, non-fatal myocardial infarction, unplanned revascularization, cerebrovascular accident, and cardiovascular readmission. Associations between baseline geometry-function phenotypes and outcomes were assessed using multivariable Cox proportional hazards models. Results The incidence of MACCE increased stepwise from group A to D (13.2%, 13.5%, 16.8%, and 21.9%, respectively). In fully adjusted analyses, LV dilatation was not associated with increased risk in patients with preserved LVEF [group B vs. group A: hazard ratio (HR), 1.13; 95% confidence interval, 0.99–1.29]. In contrast, LV dilatation was associated with a higher risk when accompanied by reduced LVEF [group C: HR, 1.12 (1.01–1.24); group D: HR, 1.44 (1.29–1.60)]. Conclusions The prognostic significance of LV dilatation after AMI depends on underlying systolic function. While LV dilatation alone may reflect a compensatory process in preserved LVEF, its presence in reduced LVEF identifies a high-risk phenotype. An integrated assessment of LV geometry and function may provide complementary risk stratification beyond conventional LVEF-based assessment.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) conducted an observational in Acute myocardial infarction (n=19,664). Dilated left ventricle with reduced ejection fraction (Group D) vs. Non-dilated left ventricle with preserved ejection fraction (Group A) was evaluated on 3-year major adverse cardiac and cerebrovascular events (MACCE) (HR 1.44, 95% CI 1.29-1.60). Left ventricular dilatation accompanied by reduced ejection fraction after acute myocardial infarction was associated with a higher risk of major adverse cardiac and cerebrovascular events compared to non-dilated, preserved ejection fraction (HR 1.44).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: